Pfizer logo is reflected in a drop on a syringe needle in this illustration photo (Reuters) -Pfizer Inc plans to tap the gene-based technology behind its successful COVID-19 shot to develop new ...

Pfizer Inc plans to tap the gene-based technology behind its successful COVID-19 shot to develop new vaccines for other viruses, the Wall Street Journal reported on Tuesday. The drugmaker, which ...

Pfizer Inc plans to tap mRNA technology to make new vaccines for other viruses following the success of its COVID-19 shot, which was developed jointly with German partner BioNTech SE, the Wall Street ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

Moderna MRNA has filed lawsuits against rivals Pfizer PFE and BioNTech BNTX, alleging that their COVID-19 vaccine, Comirnaty infringes on patents related to its mRNA technology platform. The ...

(Reuters) - CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA technology and that a U.S. court had granted its request ...

FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

Moderna filed a lawsuit against Pfizer and BioNTech claiming the biopharmaceutical companies infringed on Moderna’s patents related to mRNA technology in development of their COVID-19 vaccine. The ...

When Dr. Anna Blakney interviewed for a position at the University of British Columbia at the start of 2020, mRNA technology—her area of research expertise—wasn’t yet widely known by the general ...

March 23 (Reuters) - Pfizer Inc plans to tap the gene-based technology behind its successful COVID-19 shot to develop new vaccines for other viruses, the Wall Street Journal reported on Tuesday. The ...